Zobrazeno 1 - 10
of 1 736
pro vyhledávání: '"b7-h3"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Renal cell carcinoma (RCC) is characterised by its immunogenic and proangiogenic nature and its resistance to conventional therapies. The advent of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) has sign
Externí odkaz:
https://doaj.org/article/cbcacb4b5d25416b936cb408f3b2f179
Autor:
Meghan M. Lynch, Rusul Al-Marayaty, Farres Obeidin, Borislav A. Alexiev, Eleanor Y. Chen, Pedro Viveiros, Brett A. Schroeder, Kelly Hudkins, Timothy M. Fan, Mary W. Redman, Kelsey K. Baker, George Jour, Lee D. Cranmer, Seth M. Pollack
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Purpose Targeted therapy development in soft tissue sarcoma (STS) has been burdened by the heterogeneity of this group of rare tumors. B7 homolog 3 protein (B7-H3) is a molecule in the same family as programmed death-ligand 1 (PD-L1). It has
Externí odkaz:
https://doaj.org/article/5a52234e7e2948d482864a9aab1ae830
Autor:
Ilona Hagelstein, Laura Wessling, Alexander Rochwarger, Latifa Zekri, Boris Klimovich, Christian M. Tegeler, Gundram Jung, Christian M. Schürch, Helmut R. Salih, Martina S. Lutz
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Breast cancer (BC) is the most common malignancy in women. Immunotherapy has revolutionized treatment options in many malignancies, and the introduction of immune checkpoint inhibition yielded beneficial results also in BC. Howeve
Externí odkaz:
https://doaj.org/article/4fe2b27d65564a37932f57ac8d6d6e06
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maite Emaldi, Esther Rey-Iborra, Ángela Marín, Lorena Mosteiro, David Lecumberri, Tove Øyjord, Noémie Roncier, Gunhild M. Mælandsmo, Javier C. Angulo, Peio Errarte, Gorka Larrinaga, Rafael Pulido, José I. López, Caroline E. Nunes-Xavier
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) are improving the response rates of advanced renal cancer patients. However, many treated patients do not respond, making novel immune checkpoint-based immunotherapies
Externí odkaz:
https://doaj.org/article/949a689eebfb4f5cad6f292d3f117000
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Cancer has emerged as the second most prevalent disease and the leading cause of death, claiming the lives of 10 million individuals each year. The predominant varieties of cancer encompass breast, lung, colon, rectal, and prostate cancers. Among the
Externí odkaz:
https://doaj.org/article/9a2b87d3541a40d2a372bd5813f69bc3
Autor:
Xialin Xiong, Hang Zhou, Xinzhi Xu, Qihuan Fu, Yujie Wan, Yuting Cao, Rui Tang, Fang Li, Jun Zhang, Pan Li
Publikováno v:
Cancer Medicine, Vol 13, Iss 20, Pp n/a-n/a (2024)
ABSTRACT Background High‐intensity focused ultrasound (HIFU) is a promising minimally invasive treatment for liver cancer; however, its efficacy is often limited by the attenuation of ultrasonic energy. This study investigates the effectiveness of
Externí odkaz:
https://doaj.org/article/23a211c309e54c6887b3b4c737150705
Autor:
Abiye Tigabu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Bacterial and viral infections cause a huge burden to healthcare settings worldwide, and mortality rates associated with infectious microorganisms have remained high in recent decades. Despite tremendous efforts and resources worldwide to explore dia
Externí odkaz:
https://doaj.org/article/3fa61d7be833411999b3ae39d4fd4929
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Although most differentiated thyroid carcinoma has a clinically favorable prognosis, some of specific types of thyroid cancer (such as anaplastic thyroid carcinoma and advanced papillary thyroid carcinoma) show fatal outcomes and require nov
Externí odkaz:
https://doaj.org/article/4195ffd19bbb4c8c905e7f834bc924f7
Autor:
Maryam Oroujeni, Matilda Carlqvist, Eva Ryer, Anna Orlova, Vladimir Tolmachev, Fredrik Y. Frejd
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-19 (2024)
Abstract Background Radionuclide molecular imaging can be used to visualize the expression levels of molecular targets. Affibody molecules, small and high affinity non-immunoglobulin scaffold-based proteins, have demonstrated promising properties as
Externí odkaz:
https://doaj.org/article/3f8212334a824f1798b022f16777c967